Should You Hold Acumen Pharmaceuticals Inc (ABOS) in Biotechnology Industry?

Acumen Pharmaceuticals Inc (ABOS) is near the top in its industry group according to InvestorsObserver. ABOS gets an overall rating of 65. That means it scores higher than 65 percent of stocks. Acumen Pharmaceuticals Inc gets a 73 rank in the Biotechnology industry. Biotechnology is number 23 out of 148 industries.

ABOS has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on ABOS!

See Full ABOS Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 65 would rank higher than 65 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Acumen Pharmaceuticals Inc Stock Today?

Acumen Pharmaceuticals Inc (ABOS) stock is lower by -8.14% while the S&P 500 is up 0.12% as of 11:13 AM on Monday, May 22. ABOS has fallen -$0.49 from the previous closing price of $5.96 on volume of 195,406 shares. Over the past year the S&P 500 has risen 5.62% while ABOS is up 58.84%. ABOS lost -$1.11 per share the over the last 12 months. Click Here to get the full Stock Report for Acumen Pharmaceuticals Inc stock.